AMERICAN CENTURY COMPANIES INC
Position in EWTX — Edgewise Therapeutics, Inc.
CIK 748054
KANSAS CITY, MO
Position in EWTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$36,136,044
+$6,693,866 QoQ
Shares Held
1,147,176
-3.3% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 85.65268101843134.ToString("F0")%
Shared 14.347318981568652.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERICAN CENTURY COMPANIES INC holds $3,844,311,104 across 169 Biotechnology names. EWTX ranks #26 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,802,363 | $596,347,845 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
562,097 | $434,298,626 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
813,285 | $363,164,283 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,397,119 | $319,563,028 | |
| 5 | INSM |
INSMED Inc
|
925,799 | $151,386,652 | |
| 6 | ARGX |
Argenx SE
|
173,700 | $126,844,425 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,663,803 | $124,934,967 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
4,138,416 | $102,467,180 |
All Filings in EWTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,136,044 | 1,147,176 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $29,442,178 | 1,186,467 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $17,768,572 | 1,095,473 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $10,267,306 | 783,166 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $17,154,852 | 779,766 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $20,568,425 | 770,353 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $24,938,789 | 934,387 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $15,489,806 | 860,067 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $10,202,252 | 559,334 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $8,428,744 | 770,452 | Shares | Defined | 2024-02-13 | |
| 2023-06-30 | $4,033,890 | 520,502 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,395,443 | 509,062 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $4,520,806 | 505,683 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,908,792 | 498,861 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,425,515 | 304,713 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,957,345 | 304,881 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $4,650,911 | 304,379 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $4,887,239 | 294,412 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $6,277,632 | 294,310 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $9,053,752 | 278,577 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||